May 5, 2020 / 9:23 PM / a month ago

BRIEF-Jazz Pharma Reports Q1 Diluted EPS Loss 2.82 USD Vs 1.47 USD Profit Year Ago

May 5 (Reuters) - Jazz Pharmaceuticals PLC:

* Q1 REVENUE ROSE 5 PERCENT TO 535 MILLION USD

* Q1 DILUTED EPS LOSS 2.82 USD VERSUS 1.47 USD PROFIT YEAR AGO

* 2020 FULL-YEAR REVENUE GUIDANCE REDUCED DUE TO ANTICIPATED IMPACT OF COVID-19 PANDEMIC

* SEES 2020 REVENUES $2.12 BILLION - $2.26 BILLION

* SEES 2020 TOTAL NET PRODUCT SALES $2.11 BILLION - $2.24 BILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below